Contact
searchSearch
HMP Global

Schizophrenia Learning Library

Featured

Hara Oyedeji
Videos
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Kristian Dambrino, MSN
Videos
When Monotherapy Doesn’t Work: Treatment Resistance in Tardive Dyskinesia
04/08/2025
Kristian Dambrino, MSN, APRN, PMHNP
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Andrew Penn
Clinical Pearls
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
Andrew Penn, PMHNP-BC
Clinical Pearls
Best Practices for Deprescribing in Schizophrenia
12/05/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn,...
12/05/2024
Psych Congress NP Institute
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Clinical Pearls
Understanding Antipsychotic-Induced Movement Disorders
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress NP Institute
Jonathan Meyer
Clinical Pearls
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
10/09/2024
Jonathan Meyer, MD
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into...
10/09/2024
Psych Congress NP Institute
amber hoberg
Clinical Pearls
Treating New Patients on Preexisting First-Generation Antipsychotic Regimens
08/20/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN,...
08/20/2024
Psych Congress NP Institute
Amber and Desiree
Rapid Refresh
How to Properly Manage Missed Doses of Long-Acting Injectable Medications
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC; Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and...
08/12/2024
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Reconceptualizing Treatment-Resistant Depression as Monoamine Treatment-Resistant Depression
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
A Strategic Approach to Billing Codes
08/19/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, talk about some of the considerations surrounding billing and E&M codes
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, talk about some of the considerations surrounding billing and E&M codes
Julie Carbray, PhD, PMHNP-BC,...
08/19/2025
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
Overcoming Documentation Challenges
08/12/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss common documentation challenges and talk about some of the potential ways to overcome them.
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss common documentation challenges and talk about some of the potential ways to overcome them.
Julie Carbray, PhD, PMHNP-BC,...
08/12/2025
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
A Closer Look at Documentation Practices
08/05/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss the main reasons why APPs take documentation in their practice and identify areas where improvement may be possible.
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss the main reasons why APPs take documentation in their practice and identify areas where improvement may be possible.
Julie Carbray, PhD, PMHNP-BC,...
08/05/2025
Psych Congress NP Institute
Andrew Penn and Saundra Jain
Videos
When a Patient is Resistant to Psychotherapy
07/15/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Saundra Jain MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss what to do when a patient who has been referred to psychotherapy expresses doubt or resistance to the treatment plan.
Saundra Jain MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss what to do when a patient who has been referred to psychotherapy expresses doubt or resistance to the treatment plan.
Saundra Jain MA, PsyD, LPC, and...
07/15/2025
Psych Congress NP Institute
Andrew Penn and Saundra Jain
APP Perspectives
Integrating Psychotherapy Alongside Psychopharmacology
07/10/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and...
07/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Pearls
The Role of NMDA and AMPA Receptors in Rapid-Acting Antidepressant Treatments
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, MSN, APRN, PMHNP
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute

Rapid Refresh

Amber and Desiree
Rapid Refresh
How to Properly Manage Missed Doses of Long-Acting Injectable Medications
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC; Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and...
08/12/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Amber and Desiree
Rapid Refresh
How to Properly Manage Missed Doses of Long-Acting Injectable Medications
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC; Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, explore how to tackle missed doses and follow prescribing instructions for different LAIs to ensure you are providing the best care possible for your patient with...
Desiree Matthews, PMHNP-BC, and...
08/12/2024
Psych Congress NP Institute
Julie Carbray
Rapid Refresh
Screening Tools for Adult and Pediatric ADHD
07/26/2024
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute
andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Brooke and Amber
Rapid Refresh
Comparing MDD With Mixed Features and Bipolar I Disorder
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke...
04/10/2024
Psych Congress NP Institute

Clinical Pearls

Hara Oyedeji
Videos
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Kristian Dambrino, MSN
Videos
When Monotherapy Doesn’t Work: Treatment Resistance in Tardive Dyskinesia
04/08/2025
Kristian Dambrino, MSN, APRN, PMHNP
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Andrew Penn
Clinical Pearls
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
Andrew Penn, PMHNP-BC
Clinical Pearls
Best Practices for Deprescribing in Schizophrenia
12/05/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn,...
12/05/2024
Psych Congress NP Institute
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Clinical Pearls
Understanding Antipsychotic-Induced Movement Disorders
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress NP Institute
Jonathan Meyer
Clinical Pearls
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
10/09/2024
Jonathan Meyer, MD
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into...
10/09/2024
Psych Congress NP Institute
amber hoberg
Clinical Pearls
Treating New Patients on Preexisting First-Generation Antipsychotic Regimens
08/20/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN,...
08/20/2024
Psych Congress NP Institute
Desiree Matthews
Clinical Pearls
Achieving Therapeutic Plasma Concentration Levels With Oral Overlap, IM Loading Doses When Administering LAIs
07/19/2024
Desiree Matthews, PHMNP-BC
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the...
07/19/2024
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Pearls
Reconceptualizing Treatment-Resistant Depression as Monoamine Treatment-Resistant Depression
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, MSN, APRN, PMHNP
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Videos
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Pearls
The Role of NMDA and AMPA Receptors in Rapid-Acting Antidepressant Treatments
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, MSN, APRN, PMHNP
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute
headshot of Dr Craig Chepke
Videos
Effective Communication Strategies for Introducing LAIs in Telemedicine Settings
04/16/2025
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD, DFAPA, discusses effective communication strategies clinicians can use when introducing long-acting injectable (LAI) antipsychotics to patients for the treatment of schizophrenia.
In this video, Craig Chepke, MD,...
04/16/2025
Psych Congress Network
headshot of Dr Julie Carbray
Q&As
How Clinicians Can Navigate Stimulant vs Nonstimulant Treatments for ADHD
04/11/2025
Julie A. Carbray, PhD, APRN
2025 Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, shares how clinicians can best navigate between stimulant and nonstimulant treatment options for patients with ADHD.
2025 Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, shares how clinicians can best navigate between stimulant and nonstimulant treatment options for patients with ADHD.
2025 Psych Congress NP Institute...
04/11/2025
Psych Congress NP Institute
Kristian Dambrino, MSN
Videos
When Monotherapy Doesn’t Work: Treatment Resistance in Tardive Dyskinesia
04/08/2025
Kristian Dambrino, MSN, APRN, PMHNP
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Andrew Penn
Clinical Pearls
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute

Perspectives

Amber Hoberg
APP Perspectives
Dispelling Misconceptions and Building Therapeutic Alliances in Schizophrenia Treatment
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, of Morningstar Family Medicine, addresses the common misconceptions around patients with schizophrenia that can hinder treatment success.
Amber Hoberg, MSN, APRN, PMHNP-BC, of Morningstar Family Medicine, addresses the common misconceptions around patients with schizophrenia that can hinder treatment success.
Amber Hoberg, MSN, APRN,...
08/12/2024
Psych Congress NP Institute
Amber Hoberg
APP Perspectives
Matching Interventions and Goals in Antipsychotic Treatment for Patient-Centered Care
07/22/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN,...
07/22/2024
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
A Strategic Approach to Billing Codes
08/19/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, talk about some of the considerations surrounding billing and E&M codes
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, talk about some of the considerations surrounding billing and E&M codes
Julie Carbray, PhD, PMHNP-BC,...
08/19/2025
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
Overcoming Documentation Challenges
08/12/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss common documentation challenges and talk about some of the potential ways to overcome them.
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss common documentation challenges and talk about some of the potential ways to overcome them.
Julie Carbray, PhD, PMHNP-BC,...
08/12/2025
Psych Congress NP Institute
Desiree Matthews and Julie Carbray
APP Perspectives
A Closer Look at Documentation Practices
08/05/2025
Desiree Matthews, PHMNP-BC; Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss the main reasons why APPs take documentation in their practice and identify areas where improvement may be possible.
Julie Carbray, PhD, PMHNP-BC, APRN, and Desiree Matthews, PMHNP-BC, discuss the main reasons why APPs take documentation in their practice and identify areas where improvement may be possible.
Julie Carbray, PhD, PMHNP-BC,...
08/05/2025
Psych Congress NP Institute
Andrew Penn and Saundra Jain
Videos
When a Patient is Resistant to Psychotherapy
07/15/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Saundra Jain MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss what to do when a patient who has been referred to psychotherapy expresses doubt or resistance to the treatment plan.
Saundra Jain MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss what to do when a patient who has been referred to psychotherapy expresses doubt or resistance to the treatment plan.
Saundra Jain MA, PsyD, LPC, and...
07/15/2025
Psych Congress NP Institute
Andrew Penn and Saundra Jain
APP Perspectives
Integrating Psychotherapy Alongside Psychopharmacology
07/10/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC; Saundra Jain, MA, PsyD, LPC
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP-BC, discuss the importance and utility of integrating psychotherapy into their everyday clinical practice.
Saundra Jain, MA, PsyD, LPC, and...
07/10/2025
Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Clarifying Common Misconceptions About Treating Anxiety in Women
03/30/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...
Anxiety in women is often...
03/30/2025
Psych Congress NP Institute
(Left to right) Moushumi Mukerji, MSN, PMHNP-BC, CNM and Vanessa Joy Walker, CPC, MPH Candidate.
Clinical Pearls
Adopting a Life-Stage Lens for Anxiety Treatment in Women
03/29/2025
Moushumi Mukerji, MSN, PMHNP-BC; Vanessa Joy Walker, CPC, MPH
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.
Moushumi Mukerji, MSN, PMHNP-BC,...
03/29/2025
Psych Congress NP Institute
Chelsie Monroe and Desiree Matthews
APP Perspectives
How Psychiatric NPs Can Broaden Their Career Horizons
03/28/2025
Chelsie Monroe, PMHNP-BC, APN; Desiree Matthews, PHMNP-BC
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute Steering Committee Members Chelsie Monroe, PMHNP-BC, APN, and Desiree Matthews, PMHNP-BC, reflect on the lessons they wish they’d learned earlier in their NP careers and offer practical advice for those whose...
Psych Congress NP Institute...
03/28/2025
Psych Congress NP Institute
Amber Hoberg
APP Perspectives
Dispelling Misconceptions and Building Therapeutic Alliances in Schizophrenia Treatment
08/12/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, of Morningstar Family Medicine, addresses the common misconceptions around patients with schizophrenia that can hinder treatment success.
Amber Hoberg, MSN, APRN, PMHNP-BC, of Morningstar Family Medicine, addresses the common misconceptions around patients with schizophrenia that can hinder treatment success.
Amber Hoberg, MSN, APRN,...
08/12/2024
Psych Congress NP Institute
Amber Hoberg
APP Perspectives
Matching Interventions and Goals in Antipsychotic Treatment for Patient-Centered Care
07/22/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN,...
07/22/2024
Psych Congress NP Institute

Expert Insights Quizzes

Pop quiz written on a blackboard with white chalk
Guidelines Quiz
Side Effect Monitoring on Clozapine
07/22/2025
Test your guideline knowledge with this quiz!
Test your guideline knowledge with this quiz!
Test your guideline knowledge...
07/22/2025
Psych Congress NP Institute
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
LAI representation
Quiz
What is the next step if a patient misses a dose of an LAI medication?
08/15/2024
Meagan Thistle
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has...
08/15/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
quiz
Quiz
Are there FDA-approved LAIs for patients under 18 years with schizophrenia?
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there...
07/19/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
Tolerability Testing LAIs for Schizophrenia Treatment
07/15/2024
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not...
07/15/2024
Psych Congress NP Institute
Pop quiz written on a blackboard with white chalk
Guidelines Quiz
Side Effect Monitoring on Clozapine
07/22/2025
Test your guideline knowledge with this quiz!
Test your guideline knowledge with this quiz!
Test your guideline knowledge...
07/22/2025
Psych Congress NP Institute
What should be monitored when tapering a patient off an antidepressant?
Expert Insights Quiz
What should be monitored when tapering a patient off an antidepressant?
12/18/2024
Saundra Jain, MA, PsyD, LPC; Andrew Penn, RN, MS, NP, CNS, APRN-BC
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from a recent Q&A?
Do you remember this pearl from...
12/18/2024
Psych Congress NP Institute
What is the first step when a patient's antidepressant stops working?
Expert Insights Quiz
What is the first step when a patient's antidepressant stops working?
12/13/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
12/13/2024
Psych Congress NP Institute
pop quiz!
Quiz
What percentage of patients with TRD may have bipolar depression?
11/13/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Time to test your knowledge with a pop quiz!
Time to test your knowledge with a pop quiz!
Time to test your knowledge with...
11/13/2024
Psych Congress NP Institute
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
What is the most exciting neurotransmitter in depression treatment?
Quiz
What is the most exciting neurotransmitter in depression treatment?
10/07/2024
Rakesh Jain, MD, MPH, RD; Brooke Kempf, MSN, PMHNP-BC
Test your knowledge with a quick quiz!
Test your knowledge with a quick quiz!
Test your knowledge with a quick...
10/07/2024
Psych Congress NP Institute
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
Quiz
Which traits should clinicians look for when diagnosing MDD and bipolar disorder?
09/25/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Do you remember this interview?
Do you remember this interview?
Do you remember this interview?
09/25/2024
Psych Congress NP Institute
LAI representation
Quiz
What is the next step if a patient misses a dose of an LAI medication?
08/15/2024
Meagan Thistle
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has missed a dose of a long-acting injectable (LAI), what is the recommended first step according to a recent expert interview?
When managing a patient who has...
08/15/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Which ADHD screening tools can be found online?
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
Psych NP Institute

 

Advance Your Expertise & Gain Confidence in Your Approach at NP Institute!

Nurse Practitioners play a vital role in mental healthcare, and specialized education is key to creating the best patient outcomes. Join us at NP Institute for an in-depth, practical learning experience designed to cover everything you’ve wanted to know but have been afraid to ask.

Why Attend?

  • Expert-Led Education – Learn from world-class leaders in psychiatry
  • Deep Dive into Psychopharmacology – Master essential principles, treatments, and medications
  • Practical & Actionable – Gain confidence in your approach to manage complex cases
  • Tailored for NPs – Networking opportunities with like-minded professionals and education designed to fit your unique role in mental healthcare

Join us to expand your knowledge and enhance patient care! 

REGISTER NOW

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use